1. Supporting cutting-edge rare disease research. Canadian Institutes of Health Research. 2018; http://www.cihr-irsc.gc.ca/e/49695.html.
2. Europian Organization for Rare Diseases. Rare Diseases: Understanding This Public Health Priority. 2005; https://www.eurordis.org/IMG/pdf/princeps_document-EN.pdf.
3. U.S. Department of Health and Human Services. Orphan Drug Act. 2018; https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/OrphanDrugAct/default.htm
4. Canada’s Rare Disease Strategy. The Canadian Organization for Rare Disorders. 2017; http://www.raredisorders.ca//content/uploads/CORD_Canada_RD_Strategy_22May15.pdf
5. The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase;G Bach;Proc Natl Acad Sci USA,1973